AOD9604 peptide is a synthetic fragment of human growth hormone studied for fat loss. Learn how it works, research findings, legal status, and safety concerns.
AOD9604 is a synthetic fragment of human growth hormone that was developed and tested as a fat-loss treatment, but it failed to win regulatory approval anywhere and is not FDA-approved for human use. Human trials showed only modest, inconsistent effects on body weight, and the commercial development program was discontinued in the late 2000s. The peptide is now sold mainly as a research chemical, and bold claims that it melts fat are not supported by the evidence.
What Is the AOD9604 Peptide?
AOD9604 is built from the tail end, or C-terminal region, of human growth hormone, roughly amino acids 176–191, with a chemical modification that makes the short chain more stable. It is a fragment rather than full growth hormone, so it does not contain the parts of HGH that drive growth, blood sugar shifts, or IGF-1 production.
Online listings use several names for the same molecule, including AOD-9604, HGH fragment 176-191, peptide aod9604, and peptide aod. All of those names refer to the same synthetic compound.
It also helps to separate AOD9604 from products in the same aisle. Collagen powders and other natural peptide supplements are food-derived proteins, not synthetic hormone fragments, and they behave very differently in the body.
How AOD9604 Is Supposed to Work
Full growth hormone contains a region that increases fat breakdown, and AOD9604 was designed to isolate that specific effect. In laboratory studies on fat cells and in rodents, the peptide increased lipolysis, the release of stored fat, and reduced fat storage.
The theory is that you get the fat-metabolizing signal without the growth and metabolic side effects of full HGH. That theory has never been confirmed in large, high-quality human trials.
In research settings the peptide is usually injected subcutaneously, and vendors commonly suggest 250 to 500 mcg per day. That figure comes from early study designs rather than a validated dosing schedule. Unlike an FDA-approved peptide drug, AOD9604 has no label, no standard dose, and no required purity testing.
Oral, injectable, and topical forms
Digestive enzymes break peptides into individual amino acids, so oral AOD9604 is unlikely to reach the bloodstream intact. Topical creams and gels are also unlikely to deliver meaningful amounts through the skin barrier. Both forms still show up in weight-loss products, often blended with other unapproved compounds.
What Human Research Has Shown
The company that developed AOD9604 ran human trials in the 2000s, and early studies reported modest fat loss in some participants. When larger and longer studies were conducted, the results were not strong enough to justify continued development.
| Research stage | What was tested | Main finding |
|---|---|---|
| Lab and animal studies | Fat cells and rodents | Increased fat breakdown and reduced fat storage |
| Early human trials | Small groups of adults, injected peptide | Modest, inconsistent weight loss |
| Later-stage trials | Larger groups, longer follow-up | Results too weak to support approval |
| Development status | Commercial program | Discontinued in the late 2000s; no approval anywhere |
Most published human data come from small studies sponsored by the company that owned the peptide. Independent replication in large populations is missing, which is a common problem with unapproved compounds.
People who read about the bpc-157 peptide for inflammation at the same time often assume all research peptides are interchangeable. They are not. Each molecule has its own data set, and the AOD9604 data set is thin.
Legal Status and Sports Rules
AOD9604 is not approved by the FDA for any human use, including weight loss. In the United States, selling it as a dietary supplement or a weight-loss drug is illegal, which is why vendors label vials 'for research use only.'
The World Anti-Doping Agency bans AOD9604 at all times, and the peptide has appeared in high-profile anti-doping investigations. Athletes subject to drug testing should assume it is both prohibited and detectable.
Key point: AOD9604 is not FDA-approved for human use in the United States, and it is banned in sport at all times.
Buying research peptides online also raises sourcing questions. Vials may be underdosed, mislabeled, or contaminated, and a certificate of analysis supplied by the seller is not the same thing as independent laboratory testing.
Safety, Side Effects, and Unknowns
Short-term human trials of AOD9604 reported mostly mild reactions, such as redness or soreness at the injection site. Because those studies were small and brief, they cannot rule out uncommon or long-term harms.
A common question among buyers — are peptide supplements safe — has no single answer, because safety depends on the exact molecule, the dose, the purity, and the person. For AOD9604, there is no approved safety profile to point to.
Potential concerns with any injected research peptide include allergic reactions, immune responses to a foreign protein fragment, and infection from non-sterile technique. Injecting an unapproved substance also means there is no regulated manufacturing standard behind the product.
Anyone considering AOD9604 should discuss it with a healthcare professional, especially if they take medication for diabetes, thyroid conditions, or blood clotting. Pregnant and breastfeeding people should avoid unapproved peptides entirely.
How AOD9604 Compares With Other Weight-Loss Options
| Feature | AOD9604 | Full HGH | GLP-1 prescription drugs |
|---|---|---|---|
| FDA-approved for weight loss | No | No | Yes, for specific products |
| Typical route studied | Subcutaneous injection | Injection | Injection or oral |
| Raises IGF-1 | Little to none reported | Yes | Not applicable |
| Strength of fat-loss evidence | Weak and inconsistent | Mixed; approved for other diagnoses | Strong, from large trials |
| Legal to buy without a prescription | No | No | No |
The contrast is stark. Prescription GLP-1 medications have large peer-reviewed trials and clear labels, while full HGH is a controlled prescription drug for specific diagnoses. AOD9604 has neither approval nor robust evidence.
Scanning lists of the best peptide supplements usually turns up collagen, creatine blends, and a handful of questionable weight-loss vials, and AOD9604 typically falls in the last group. If weight loss is the goal, options with real data exist, including structured lifestyle programs, prescription medication, and bariatric surgery for eligible patients.
Even in mainstream medicine, peptides are handled carefully. Peptide drug conjugates used in cancer therapy are characterized, dosed, and monitored in ways that research chemicals never are.
Bottom Line on AOD9604
AOD9604 is an interesting molecule that never cleared the bar for approval. The evidence for fat loss is weak, the legal status is unfavorable, and the long-term safety profile is unknown.
If you see AOD9604 marketed with dramatic before-and-after photos, treat those claims as advertising rather than science. Verify information through peer-reviewed research, and be skeptical of any seller promising prescription-level results without a prescription.
Frequently Asked Questions
Does AOD9604 actually help you lose weight?
Human trials of AOD9604 showed only modest and inconsistent weight loss, and later-stage studies did not produce results strong enough to support approval. The commercial development program was discontinued in the late 2000s. No large, independent trial shows that AOD9604 causes meaningful or lasting fat loss in people.
Is AOD9604 legal to buy in the US?
AOD9604 is not FDA-approved for human use, so it cannot legally be sold as a supplement or weight-loss drug in the United States. Vendors work around this by labeling vials 'for research use only,' which does not make the product legal for human consumption. Importing it for personal use is also not authorized under FDA rules for unapproved new drugs.
What side effects has AOD9604 been linked to?
Short human trials reported mostly mild reactions, including pain, redness, or swelling at the injection site. Because those studies were small and short, uncommon or long-term effects remain unknown. Any injected research peptide also carries risks from contamination, non-sterile product, or an immune reaction.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.